A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study

NCT03687827 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

498

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin degludec
DRUG: Insulin glargine

Sponsor

Novo Nordisk A/S